Apollon Formularies (AQSE:APOL) Dividend Payout Ratio : 0.00 (As of Jun. 2023)

View and export this data going back to . Start your Free Trial

What is Apollon Formularies Dividend Payout Ratio?

Apollon Formularies's dividend payout ratio for the months ended in Jun. 2023 was 0.00.

The historical rank and industry rank for Apollon Formularies's Dividend Payout Ratio or its related term are showing as below:

AQSE:APOL's Dividend Payout Ratio is not ranked ^*
in the Drug Manufacturers industry.
Industry Median: 0.335
* Ranked among companies with meaningful Dividend Payout Ratio only.

As of today (2024-06-06), the Dividend Yield % of Apollon Formularies is 0.00%.

Apollon Formularies's Dividends per Share for the months ended in Jun. 2023 was £0.00.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.

Apollon Formularies Dividend Payout Ratio Historical Data

The historical data trend for Apollon Formularies's Dividend Payout Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Apollon Formularies Dividend Payout Ratio Chart

Apollon Formularies Annual Data

Trend

Jun10

Jun11

Dec12

Dec13

Dec14

Dec17

Dec18

Dec19

Dec20

Dec21

Dividend Payout Ratio

Get a 7-Day Free Trial

Apollon Formularies Semi-Annual Data
	Jun11	Jun12	Jun13	Dec13	Jun14	Dec14	Jun15	Dec17	Dec18	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Jun23
Dividend Payout Ratio	Get a 7-Day Free Trial											-	-	-	-	-

Competitive Comparison of Apollon Formularies's Dividend Payout Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Apollon Formularies's Dividend Payout Ratio, along with its competitors' market caps and Dividend Payout Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Apollon Formularies's Dividend Payout Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Apollon Formularies's Dividend Payout Ratio distribution charts can be found below:

* The bar in red indicates where Apollon Formularies's Dividend Payout Ratio falls into.

Apollon Formularies Dividend Payout Ratio Calculation

Dividend payout ratio measures the percentage of the company's earnings paid out as dividends.

Apollon Formularies's Dividend Payout Ratio for the fiscal year that ended in Dec. 2021 is calculated as

Dividend Payout Ratio	=	Dividends per Share (A: Dec. 2021 )	/	EPS without NRI (A: Dec. 2021 )
	=	0	/	-0.002
	=	N/A

Apollon Formularies's Dividend Payout Ratio for the quarter that ended in Jun. 2023 is calculated as

Dividend Payout Ratio	=	Dividends per Share (Q: Jun. 2023 )	/	EPS without NRI (Q: Jun. 2023 )
	=	0	/	-0.001
	=	N/A

Apollon Formularies (AQSE:APOL) Dividend Payout Ratio Explanation

In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.

Apollon Formularies Dividend Payout Ratio Related Terms

Thank you for viewing the detailed overview of Apollon Formularies's Dividend Payout Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.

Apollon Formularies (AQSE:APOL) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Apollon Formularies PLC (AQSE:APOL) » Definitions » Dividend Payout Ratio

Comparable Companies

Traded in Other Exchanges

N/A

Address

6 Hope Street, Quayside House, Castletown, IMN, IM9 1AS

Website

https://www.apollon.org.uk

Apollon Formularies PLC is a London, England and Jamaican based medical cannabis pharmaceutical company specialising in research and treatment of patients with cancer and chronic pain. It is engaged in investing by seeking to acquire a direct and/or indirect interest in projects and assets in the agriculture and logistics sectors and the medicinal cannabis sector. The company focus on opportunities in Africa and Europe. It has created proprietary hybrid medical cannabis pharmaceutical strains, technology, formulations, and treatment products.